PMC:1310901 / 2260-2377 JSONTXT

{"project":"bionlp-st-ge-2016-reference-eval","denotations":[{"id":"T2680","span":{"begin":18,"end":30},"obj":"Protein"},{"id":"T2691","span":{"begin":32,"end":37},"obj":"Protein"}],"relations":[{"id":"R2110","pred":"equivalentTo","subj":"T2691","obj":"T2680"}],"text":"). Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogeneti"}

{"project":"events-check-again","denotations":[{"id":"T2518","span":{"begin":18,"end":30},"obj":"Protein"},{"id":"T2519","span":{"begin":32,"end":37},"obj":"Protein"}],"relations":[{"id":"R2024","pred":"equivalentTo","subj":"T2519","obj":"T2518"}],"text":"). Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogeneti"}

{"project":"pmc-enju-pas","denotations":[{"id":"T1182","span":{"begin":0,"end":1},"obj":"-RRB-"},{"id":"T1183","span":{"begin":3,"end":12},"obj":"NN"},{"id":"T1184","span":{"begin":13,"end":17},"obj":"IN"},{"id":"T1185","span":{"begin":18,"end":28},"obj":"NN"},{"id":"T1186","span":{"begin":29,"end":30},"obj":"NN"},{"id":"T1187","span":{"begin":31,"end":32},"obj":"-LRB-"},{"id":"T1188","span":{"begin":32,"end":37},"obj":"NN"},{"id":"T1189","span":{"begin":37,"end":38},"obj":"-RRB-"},{"id":"T1190","span":{"begin":39,"end":47},"obj":"VB"},{"id":"T1191","span":{"begin":48,"end":56},"obj":"NN"},{"id":"T1192","span":{"begin":57,"end":59},"obj":"IN"},{"id":"T1193","span":{"begin":60,"end":63},"obj":"NN"},{"id":"T1194","span":{"begin":64,"end":72},"obj":"NN"},{"id":"T1195","span":{"begin":73,"end":76},"obj":"CC"},{"id":"T1196","span":{"begin":77,"end":79},"obj":"VB"},{"id":"T1197","span":{"begin":80,"end":90},"obj":"VB"},{"id":"T1198","span":{"begin":91,"end":95},"obj":"IN"},{"id":"T1199","span":{"begin":96,"end":97},"obj":"DT"},{"id":"T1200","span":{"begin":98,"end":106},"obj":"JJ"}],"relations":[{"id":"R851","pred":"arg1Of","subj":"T1183","obj":"T1184"},{"id":"R852","pred":"arg1Of","subj":"T1183","obj":"T1190"},{"id":"R853","pred":"arg1Of","subj":"T1183","obj":"T1196"},{"id":"R854","pred":"arg2Of","subj":"T1183","obj":"T1197"},{"id":"R855","pred":"arg2Of","subj":"T1186","obj":"T1184"},{"id":"R856","pred":"arg1Of","subj":"T1186","obj":"T1185"},{"id":"R857","pred":"arg1Of","subj":"T1186","obj":"T1187"},{"id":"R858","pred":"arg2Of","subj":"T1188","obj":"T1187"},{"id":"R859","pred":"arg3Of","subj":"T1189","obj":"T1187"},{"id":"R860","pred":"arg1Of","subj":"T1190","obj":"T1195"},{"id":"R861","pred":"arg2Of","subj":"T1191","obj":"T1190"},{"id":"R862","pred":"arg1Of","subj":"T1191","obj":"T1192"},{"id":"R863","pred":"arg2Of","subj":"T1194","obj":"T1192"},{"id":"R864","pred":"arg1Of","subj":"T1194","obj":"T1193"},{"id":"R865","pred":"arg2Of","subj":"T1197","obj":"T1195"},{"id":"R866","pred":"arg2Of","subj":"T1197","obj":"T1196"},{"id":"R867","pred":"arg1Of","subj":"T1197","obj":"T1198"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"). Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogeneti"}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T1804","span":{"begin":0,"end":1},"obj":"-RRB-"},{"id":"T1805","span":{"begin":1,"end":2},"obj":"."},{"id":"T1806","span":{"begin":3,"end":12},"obj":"NNP"},{"id":"T1807","span":{"begin":13,"end":17},"obj":"IN"},{"id":"T1808","span":{"begin":18,"end":28},"obj":"NN"},{"id":"T1809","span":{"begin":29,"end":30},"obj":"NN"},{"id":"T1810","span":{"begin":31,"end":32},"obj":"-LRB-"},{"id":"T1811","span":{"begin":32,"end":37},"obj":"NNP"},{"id":"T1812","span":{"begin":37,"end":38},"obj":"-RRB-"},{"id":"T1813","span":{"begin":39,"end":47},"obj":"NNS"},{"id":"T1814","span":{"begin":48,"end":56},"obj":"NN"},{"id":"T1815","span":{"begin":57,"end":59},"obj":"IN"},{"id":"T1816","span":{"begin":60,"end":63},"obj":"NNP"},{"id":"T1817","span":{"begin":64,"end":72},"obj":"NNS"},{"id":"T1818","span":{"begin":73,"end":76},"obj":"CC"},{"id":"T1819","span":{"begin":77,"end":79},"obj":"VBZ"},{"id":"T1820","span":{"begin":80,"end":90},"obj":"VBN"},{"id":"T1821","span":{"begin":91,"end":95},"obj":"IN"},{"id":"T1822","span":{"begin":96,"end":97},"obj":"DT"},{"id":"T1823","span":{"begin":98,"end":106},"obj":"JJ"}],"relations":[{"id":"R1429","pred":"nsubj","subj":"T1806","obj":"T1813"},{"id":"R1430","pred":"prep","subj":"T1807","obj":"T1806"},{"id":"R1431","pred":"compound","subj":"T1808","obj":"T1809"},{"id":"R1432","pred":"pobj","subj":"T1809","obj":"T1807"},{"id":"R1433","pred":"punct","subj":"T1810","obj":"T1811"},{"id":"R1434","pred":"appos","subj":"T1811","obj":"T1809"},{"id":"R1435","pred":"punct","subj":"T1812","obj":"T1806"},{"id":"R1436","pred":"ROOT","subj":"T1813","obj":"T1813"},{"id":"R1437","pred":"dobj","subj":"T1814","obj":"T1813"},{"id":"R1438","pred":"prep","subj":"T1815","obj":"T1814"},{"id":"R1439","pred":"compound","subj":"T1816","obj":"T1817"},{"id":"R1440","pred":"pobj","subj":"T1817","obj":"T1815"},{"id":"R1441","pred":"cc","subj":"T1818","obj":"T1813"},{"id":"R1442","pred":"auxpass","subj":"T1819","obj":"T1820"},{"id":"R1443","pred":"conj","subj":"T1820","obj":"T1813"},{"id":"R1444","pred":"prep","subj":"T1821","obj":"T1820"}],"text":"). Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogeneti"}

{"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T2571","span":{"begin":18,"end":30},"obj":"Protein"},{"id":"T2572","span":{"begin":32,"end":37},"obj":"Protein"}],"text":"). Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogeneti"}

{"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T1007","span":{"begin":18,"end":30},"obj":"Protein"},{"id":"T1008","span":{"begin":32,"end":37},"obj":"Protein"}],"relations":[{"id":"R749","pred":"equivalentTo","subj":"T1008","obj":"T1007"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"). Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogeneti"}

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T1675","span":{"begin":32,"end":37},"obj":"P01562"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"). Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogeneti"}

{"project":"test2","denotations":[{"id":"T955","span":{"begin":18,"end":30},"obj":"Protein"},{"id":"T956","span":{"begin":32,"end":37},"obj":"Protein"}],"relations":[{"id":"R722","pred":"equivalentTo","subj":"T956","obj":"T955"}],"text":"). Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogeneti"}